Inhaled Covid-19 vaccine
Iconovo reports Q3 and organizes pandemic event
Iconovo has recently published its third quarter report, reporting on progress in projects and increased revenue...
Iconovo's CEO looks back on an eventful 2021
In 2021, inhalation company Iconovo has managed to row in...
Intervju
Iconovo joins the vaccine race
All COVID-19 vaccines currently on the market...
First approved patent in the US for Iconovo's ICOone
ICOone is Iconovo's single-dose inhaler for simple and cost-effective...